Treating Breast Cancer Brain Mets - Metastatic Breast Cancer Trial Talk

Research News

Treatment options for breast cancer brain metastases (BCBM) have historically included only surgery, radiation, and limited clinical trial access. However, due to ongoing research, newly approved therapies, and changes to clinical trials design that allow more people with BCBM to enroll, there are now more treatment options available. Moreover, these new findings impact people with HER2 positive, hormone-positive, and triple-negative BCBM.

See below for an overview of current research and evidence on new therapies for BCBM.  (Some of these articles also discuss leptomeningeal metastasis.)

Slide Presentations 
Clinical Trials Studying BCBM

Last Modified on March 26, 2021



for past articles or specific information.